Literature DB >> 17634701

Hypoxic hepatopathy: pathophysiology and prognosis.

Richard Birrer1, Yasuharu Takuda, Tsuyoshi Takara.   

Abstract

BACKGROUND: Dramatic transient elevation in serum concentrations of hepatic enzymes occurs in some patients following a hypo-perfusion state. This entity is variously termed "shock liver" or "ischemic hepatitis", since the pathogenesis is considered to be ischemia. However, hypotension or shock is not always present.
METHODS: We analyzed the medical records of 293 patients (322 episodes) who had a hypoxic state and were admitted to the critical care units of two general hospitals over a 13-year period.
RESULTS: Hepatic injury was identified in about 1% of patients in critical care admissions. In addition to hypotension, the causes for hepatic injury were a low flow state secondary to congestive heart failure and hypoxia from sepsis or respiratory failure and hypoxemia from a variety of etiologies. These values were mostly normalized within several days when the hypoxic etiology was corrected and a serious co-morbid state did not intervene.
CONCLUSION: Marked elevation of hepatic enzymes can be identified not only in patients with hypotension, but also in normotensive patients in hypoxic state. Thus, the condition is appropriately termed hypoxic hepatopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17634701     DOI: 10.2169/internalmedicine.46.0059

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  54 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Ischemic Hepatitis - Intercorrelated Pathology.

Authors:  Andrea Olivia Ciobanu; Leonida Gherasim
Journal:  Maedica (Bucur)       Date:  2018-03

Review 4.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

5.  Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock.

Authors:  Christian Jung; Georg Fuernau; Ingo Eitel; Steffen Desch; Gerhard Schuler; Malte Kelm; Volker Adams; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-12-08       Impact factor: 5.460

6.  Glucagon-like peptide-2 exhibits protective effect on hepatic ischemia-reperfusion injury in rats.

Authors:  Naci Topaloğlu; Adem Küçük; Şule Yıldırım; Mustafa Tekin; Havva Erdem; Mustafa Deniz
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 7.  [Shock liver and cholestatic liver in critically ill patients].

Authors:  A Drolz; T Horvatits; K Roedl; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-27       Impact factor: 0.840

8.  Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusion.

Authors:  Wu Deng; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2013-09-16

9.  'Liver function tests' on the intensive care unit: a prospective, observational study.

Authors:  S J Thomson; M L Cowan; I Johnston; S Musa; M Grounds; T M Rahman
Journal:  Intensive Care Med       Date:  2009-06-10       Impact factor: 17.440

10.  The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension.

Authors:  Yuksel Dogan; Aliye Soylu; Ozgur Kilickesmez; Tuna Demirtas; Kadriye Orta Kilickesmez; Sebahat Nacar Dogan; Gulay Eren; Isa Sevindir; Nurgul Yasar; Sule Poturoglu; Kenan Sonmez
Journal:  Cardiovasc Ultrasound       Date:  2010-07-21       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.